RICHMOND, BRITISH COLUMBIA--(Marketwire - April 15, 2008) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV), a medical devices company specializing in products for the vascular and surgical markets, provides the following progress update on its pre-market approval (PMA) application for the Metricath Gemini® dual-balloon angioplasty catheter:
